Merck & Co. said Friday that the recently enacted U.S. health-care overhaul legislation would reduce its revenue by $170 million this year and up to $350 million next year, but the drug maker reaffirmed its long-term profit forecast.
Apr25
Merck & Co. said Friday that the recently enacted U.S. health-care overhaul legislation would reduce its revenue by $170 million this year and up to $350 million next year, but the drug maker reaffirmed its long-term profit forecast.